Title |
The Exceptional Oncogenicity of HTLV-1
|
---|---|
Published in |
Frontiers in Microbiology, August 2017
|
DOI | 10.3389/fmicb.2017.01425 |
Pubmed ID | |
Authors |
Yutaka Tagaya, Robert C. Gallo |
Abstract |
Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus identified in 1979 by the Gallo group. HTLV-1 causes fatal T-cell leukemia (adult T cell leukemia) and a progressive myelopahy (HTLV-1-associated myelopathy/ tropical spastic paraparesis, HAM/TSP) and other disorders. Since the discovery of HTLV-1, several other microorganisms are demonstrated to cause cancer in humans. In this article, we investigated the oncogenic capacity of HTLV-1, in comparison with those of other oncoviruses and one oncobacterium (Helicobacter pylori, H. Pylori) based on published literature. We conclude here that HTLV-1 is one of the most and may be the most carcinogenic among them and arguably one of the most potent of the known human carcinogens. This fact has not been noted before and is particularly important to justify why we need to study HTLV-1 as an important model of human viral oncogenesis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 43% |
Brazil | 1 | 7% |
Unknown | 7 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 71% |
Practitioners (doctors, other healthcare professionals) | 2 | 14% |
Science communicators (journalists, bloggers, editors) | 1 | 7% |
Scientists | 1 | 7% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 77 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 13% |
Student > Master | 10 | 13% |
Student > Bachelor | 10 | 13% |
Student > Doctoral Student | 7 | 9% |
Student > Postgraduate | 4 | 5% |
Other | 11 | 14% |
Unknown | 25 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 16 | 21% |
Medicine and Dentistry | 12 | 16% |
Agricultural and Biological Sciences | 9 | 12% |
Immunology and Microbiology | 5 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 8 | 10% |
Unknown | 25 | 32% |